Authorised Therapeutic confirmatory (Phase III) Infertility, diminished ovarian reserve.

An RCT investigating hCG priming in women with diminished ovarian reserve

Q: Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Q: Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

Q: How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Q: Who can join this trial?

This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.

EU CTIS ID: 2025-521234-28-00

What this study is testing

The aim of the study is to examine the effects of low dose hCG priming for eight weeks in women with DOR undergoing IVF/ICSI. We want to retest the findings of our pilot study (Friis Wang et al. 2023), as an increase of 50% in number of oocytes retrieved is clinically relevant.

Therapeutic confirmatory (Phase III)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

Female, Age 18-40 (both inclusive), Regular menstrual cycle (23-35 days), 1.-5. IVF/ICSI cycle at inclusion, AMH < 6.29 pmol/L (Elecsys® AMH assay)

You likely can't join if

Uterine malformations or hydrosalpinx, Submucosal uterine myomas, Uterine polyps, Allergy to standard IVF/ICSI medication, Endometriosis stage III-IV, Preimplantation genetic testing, Testicular sperm aspiration/extraction, Known severe comorbidity

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.

Explore other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH)Heart failure Coronary artery disease

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.